Tandem Diabetes Care (TNDM)

Nasdaq Health Care Health Care Equipment S&P SmallCap 600

$16.91

-1.08 (-6.00%)

Close of Nov 06, 2026 · end-of-day data

Source: Tandem Diabetes Care's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 09, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$84.25M	$107.60M	$183.87M	$362.31M	$498.83M	$702.80M	$801.22M	$747.72M	$940.20M	$1.01B
Cost of revenue	$60.66M	$63.51M	$94.04M	$168.09M	$238.31M	$326.58M	$388.23M	$380.03M	$450.63M	$468.72M
Gross profit	$23.59M	$44.09M	$89.82M	$194.21M	$260.52M	$376.21M	$412.99M	$367.69M	$489.57M	$546.01M
Research & development	$18.81M	$20.66M	$29.23M	$45.20M	$63.57M	$92.05M	$139.11M	$169.67M	$198.88M	$193.11M
Selling, general & admin	$82.83M	$86.38M	$105.23M	$165.74M	$204.90M	$261.51M	$335.68M	$352.50M	$389.82M	$444.99M
Operating income	-$78.05M	-$62.94M	-$44.63M	-$16.72M	-$7.96M	$22.65M	-$92.85M	-$233.23M	-$99.13M	-$187.26M
Interest expense	—	—	—	—	—	—	$6.21M	$9.88M	$7.42M	$7.91M
Pre-tax income	-$83.46M	-$73.03M	-$122.56M	-$24.60M	-$36.28M	$15.90M	-$92.85M	-$220.25M	-$91.87M	-$200.27M
Income tax	-$15.00K	$8.00K	$51.00K	$149.00K	-$1.90M	$335.00K	$1.74M	$2.36M	$4.16M	$4.44M
Net income	-$83.45M	-$73.03M	-$122.61M	-$24.75M	-$34.38M	$15.57M	-$94.59M	-$222.61M	-$96.03M	-$204.71M
EBITDA	-$72.56M	-$56.08M	-$38.81M	-$10.65M	$2.49M	$36.50M	-$78.52M	-$217.51M	-$82.52M	-$169.59M
EPS (basic)	$-27.30	$-12.87	$-2.55	$-0.42	$-0.56	$0.25	$-1.47	$-3.43	$-1.47	$-3.04
EPS (diluted)	$-27.30	$-12.87	$-2.55	$-0.42	$-0.56	$0.24	$-1.47	$-3.43	$-1.47	$-3.04
Diluted shares	3.06M	5.68M	48.13M	58.51M	60.99M	64.35M	64.15M	64.97M	65.45M	67.28M
Gross margin	28.0%	41.0%	48.9%	53.6%	52.2%	53.5%	51.5%	49.2%	52.1%	53.8%
Operating margin	-92.6%	-58.5%	-24.3%	-4.6%	-1.6%	3.2%	-11.6%	-31.2%	-10.5%	-18.5%
Net margin	-99.0%	-67.9%	-66.7%	-6.8%	-6.9%	2.2%	-11.8%	-29.8%	-10.2%	-20.2%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$44.68M	$13.70M	$41.83M	$51.17M	$94.61M	$71.18M	$172.52M	$58.87M	$69.23M	$90.63M
Short-term investments	$8.86M	$479.00K	$87.20M	$125.28M	$390.32M	$552.63M	$444.38M	$409.04M	$369.10M	$202.03M
Receivables	$11.17M	$20.79M	$35.19M	$46.59M	$82.19M	$110.72M	$114.72M	$105.56M	$114.58M	$165.49M
Inventory	$21.20M	$26.99M	$19.90M	$49.07M	$63.72M	$68.55M	$111.12M	$157.94M	$149.61M	$128.77M
Total current assets	$92.09M	$64.16M	$187.88M	$276.14M	$637.24M	$811.52M	$849.98M	$747.99M	$724.49M	$618.14M
Total assets	$112.39M	$95.35M	$206.29M	$326.11M	$716.41M	$905.14M	$1.05B	$952.66M	$967.66M	$881.11M
Total current liabilities	$31.48M	$36.09M	$66.29M	$99.40M	$103.85M	$131.86M	$165.29M	$195.26M	$247.05M	$242.72M
Short-term debt	—	—	—	—	—	—	—	$0	$40.67M	—
Long-term debt	$81.08M	$82.74M	—	—	—	—	—	$285.04M	$308.27M	$310.04M
Total debt	$81.08M	$82.74M	—	—	—	—	—	$285.04M	$348.94M	$310.04M
Total liabilities	$118.32M	$124.49M	$75.02M	$131.13M	$350.11M	$472.02M	$612.84M	$639.03M	$704.56M	$725.94M
Shareholders' equity	-$5.93M	-$29.15M	$131.28M	$194.98M	$366.31M	$433.11M	$439.95M	$313.63M	$263.10M	$155.17M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$61.17M	-$66.14M	-$8.32M	$41.91M	$24.67M	$111.36M	$50.46M	-$31.81M	$24.23M	-$9.72M
Capital expenditures	$8.93M	$5.72M	$2.99M	$19.54M	$27.41M	$14.18M	$34.10M	$26.80M	$19.23M	$19.95M
Free cash flow	-$70.10M	-$71.85M	-$11.30M	$22.36M	-$2.74M	$97.18M	$16.37M	-$58.61M	$4.99M	-$29.67M
Investing cash flow	$10.45M	$2.78M	-$90.74M	-$56.95M	-$296.06M	-$186.88M	$33.17M	-$85.74M	-$23.48M	$72.88M
Financing cash flow	$52.31M	$40.38M	$117.18M	$24.21M	$314.44M	$51.93M	$16.88M	$4.11M	$8.37M	-$43.37M
Share buybacks	—	—	—	—	—	—	$0	$0	$30.00M	$0
Stock-based compensation	$11.66M	$12.63M	$23.74M	$58.07M	$58.43M	$60.75M	$84.92M	$88.08M	$101.38M	$92.38M
Depreciation & amortization	$5.49M	$6.87M	$5.82M	$6.07M	$10.45M	$13.85M	$14.33M	$15.71M	$16.61M	$17.67M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$196.80M	$191.67M	$221.91M	$243.97M	$282.65M	$234.42M	$240.68M	$249.25M	$290.38M	$247.22M	$254.56M	$283.69M
Cost of revenue	$103.50M	$97.00M	$109.12M	$119.32M	$125.19M	$116.02M	$114.82M	$114.96M	$122.92M	$110.43M	$109.78M	$123.27M
Gross profit	$93.30M	$94.67M	$112.79M	$124.65M	$157.46M	$118.41M	$125.86M	$134.29M	$167.46M	$136.79M	$144.78M	$160.42M
Research & development	$42.60M	$46.24M	$49.33M	$51.11M	$52.20M	$50.22M	$48.12M	$48.72M	$46.07M	$46.03M	$46.93M	$48.85M
Selling, general & admin	$85.75M	$90.11M	$94.24M	$99.64M	$105.84M	$113.85M	$109.60M	$108.44M	$113.10M	$108.19M	$111.64M	$113.94M
Operating income	-$35.06M	-$41.68M	-$30.77M	-$26.09M	-$581.00K	-$120.88M	-$51.81M	-$22.86M	$8.29M	-$17.43M	-$13.79M	-$2.37M
Interest expense	$1.80M	$1.90M	$1.79M	$1.86M	$1.86M	$1.86M	$1.91M	$2.06M	$2.08M	$2.20M	$2.45M	$2.31M
Pre-tax income	-$31.31M	-$39.53M	-$29.74M	-$22.61M	$16.00K	-$122.09M	-$57.72M	-$25.14M	$4.68M	-$19.88M	-$20.66M	-$7.69M
Income tax	-$1.31M	$3.19M	$1.07M	$637.00K	-$739.00K	$8.47M	-$5.32M	-$3.98M	$5.27M	$516.00K	$510.00K	-$608.00K
Net income	-$30.00M	-$42.72M	-$30.81M	-$23.25M	$755.00K	-$130.56M	-$52.40M	-$21.16M	-$589.00K	-$20.39M	-$21.17M	-$7.08M
EBITDA	-$31.03M	-$37.63M	-$26.67M	-$21.88M	$3.66M	-$116.57M	-$47.44M	-$18.37M	$12.79M	-$12.93M	-$9.32M	$2.14M
EPS (basic)	$-0.46	$-0.65	$-0.47	$-0.35	$0.01	$-1.97	$-0.78	$-0.31	$-0.01	$-0.30	$-0.31	$-0.10
EPS (diluted)	$-0.46	$-0.65	$-0.47	$-0.35	$0.01	$-1.97	$-0.78	$-0.31	$-0.01	$-0.30	$-0.31	$-0.10
Diluted shares	65.37M	65.33M	64.99M	65.54M	66.16M	66.40M	67.05M	67.65M	68.01M	68.40M	69.01M	69.65M
Gross margin	47.4%	49.4%	50.8%	51.1%	55.7%	50.5%	52.3%	53.9%	57.7%	55.3%	56.9%	56.5%
Operating margin	-17.8%	-21.7%	-13.9%	-10.7%	-0.2%	-51.6%	-21.5%	-9.2%	2.9%	-7.1%	-5.4%	-0.8%
Net margin	-15.2%	-22.3%	-13.9%	-9.5%	0.3%	-55.7%	-21.8%	-8.5%	-0.2%	-8.2%	-8.3%	-2.5%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$58.87M	$58.98M	$47.70M	$49.04M	$69.23M	$53.57M	$64.11M	$91.95M	$90.63M	$179.32M	$62.82M	$72.84M
Short-term investments	$409.04M	$408.83M	$404.72M	$424.27M	$369.10M	$315.05M	$251.25M	$227.16M	$202.03M	$390.93M	$393.18M	$370.24M
Receivables	$105.56M	$92.97M	$98.12M	$107.19M	$114.58M	$126.56M	$128.44M	$125.94M	$165.49M	$140.67M	$162.06M	$180.02M
Inventory	$157.94M	$153.89M	$161.66M	$152.44M	$149.61M	$141.16M	$142.57M	$137.28M	$128.77M	$126.40M	$135.11M	$143.12M
Total current assets	$747.99M	$735.19M	$733.39M	$752.83M	$724.49M	$663.43M	$614.82M	$616.94M	$618.14M	$887.10M	$804.64M	$820.72M
Total assets	$952.66M	$941.04M	$937.50M	$957.73M	$967.66M	$922.14M	$875.74M	$874.65M	$881.11M	$1.15B	$1.15B	$1.16B
Total current liabilities	$195.26M	$192.97M	$240.61M	$259.28M	$247.05M	$288.18M	$251.69M	$252.54M	$242.72M	$247.96M	$253.00M	$256.07M
Short-term debt	$0	—	$40.54M	$40.60M	$40.67M	—	—	—	—	—	—	—
Long-term debt	$285.04M	—	$307.39M	$307.83M	$308.27M	$308.70M	$309.15M	$309.59M	$310.04M	$601.77M	$602.58M	$603.39M
Total debt	$285.04M	—	$347.93M	$348.43M	$348.94M	$308.70M	$309.15M	$309.59M	$310.04M	$601.77M	$602.58M	$603.39M
Total liabilities	$639.03M	$697.98M	$703.63M	$720.02M	$704.56M	$766.85M	$742.45M	$741.69M	$725.94M	$1.02B	$1.02B	$1.02B
Shareholders' equity	$313.63M	$243.06M	$233.88M	$237.71M	$263.10M	$155.29M	$133.28M	$132.97M	$155.17M	$132.40M	$130.39M	$135.09M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	-$7.22M	-$8.00M	-$5.28M	$26.78M	$10.72M	-$18.28M	-$9.50M	$8.26M	$9.79M	$11.05M	-$34.63M	-$819.00K
Capital expenditures	$5.20M	$4.46M	$6.47M	$5.24M	$3.07M	$2.96M	$6.21M	$4.09M	$6.68M	$6.27M	$4.05M	$4.69M
Free cash flow	-$12.41M	-$12.45M	-$11.74M	$21.54M	$7.65M	-$21.24M	-$15.70M	$4.17M	$3.10M	$4.79M	-$38.68M	-$5.51M
Investing cash flow	-$16.58M	-$5.06M	-$3.54M	-$19.90M	$5.01M	$9.19M	$58.13M	$20.54M	-$14.98M	-$195.45M	-$87.34M	$17.98M
Financing cash flow	$2.62M	$13.59M	-$3.00M	-$4.52M	$2.30M	-$4.69M	-$39.71M	-$1.57M	$2.60M	$274.16M	$2.15M	-$7.03M
Share buybacks	—	$30.00M	$0	$0	$0	$0	$0	$0	$0	—	—	—
Stock-based compensation	$22.74M	$22.04M	$24.90M	$26.28M	$28.17M	$25.49M	$25.64M	$21.14M	$20.11M	$15.66M	$15.74M	$15.89M
Depreciation & amortization	$4.03M	$4.04M	$4.11M	$4.21M	$4.25M	$4.31M	$4.37M	$4.49M	$4.50M	$4.50M	$4.47M	$4.51M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.